Ongoing Salmonella Outbreak in Canada Has Sickened Almost 200

Key Takeaways

• 189 Salmonella cases linked to pistachios since March 2025.
• 26 hospitalizations across six Canadian provinces, mainly Quebec and Ontario.
• CFIA bans Iranian pistachio imports; recalls affect multiple brands.
• Vulnerable groups face higher risk of severe salmonellosis.

Pulse Analysis

The Canadian salmonella outbreak tied to pistachios has entered its second year, with public health officials confirming 189 reported illnesses and 26 hospitalizations as of April 2026. The cases span six provinces, concentrating in Quebec (88) and Ontario (74), and illustrate how a single commodity can become a vector for widespread foodborne disease. Unlike many contaminants, Salmonella leaves no visual or olfactory clues, making early detection reliant on laboratory testing and patient reporting. The protracted nature of the outbreak underscores gaps in traceability within global nut supply chains.

Regulators have responded aggressively. The Canadian Food Inspection Agency (CFIA) issued dozens of recalls covering everything from raw kernels to pistachio‑laden snack foods, and in September 2025 it imposed a blanket ban on pistachio imports from Iran, a measure that remains in force. These actions have disrupted import volumes and forced manufacturers to seek alternative sources, driving up costs for retailers and consumers. The recall cascade also highlights the importance of rapid cross‑border communication between health agencies and food producers to contain contamination.

Health officials warn that while most healthy adults recover within a week, high‑risk groups—children, seniors, pregnant women, and immunocompromised patients—can experience severe, sometimes fatal complications. Prompt medical attention and disclosure of recent pistachio consumption are critical for accurate diagnosis, as salmonellosis symptoms mimic other gastrointestinal illnesses. The outbreak serves as a reminder for consumers to stay informed about product recalls and for the industry to invest in robust testing and supply‑chain transparency. Strengthening these safeguards can reduce the likelihood of future nut‑related salmonella events.